Sie sind hier: Startseite Termine Biosimilars & Generics in the Pre-Emerging and Emerging Markets
x
Um unsere Webseite für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies erhalten Sie in unserer Datenschutzerklärung.

Biosimilars & Generics in the Pre-Emerging and Emerging Markets

You work in the field of branded generics, biosimilars or the so called generic plus products? Then this seminar will help you to identify new and upcoming markets outside the EU.
  • You work in the field of branded generics, biosimilars or the so called generic plus products? Then this seminar will help you to identify new and upcoming markets outside the EU.

    You will learn about the global regulatory framework for biosimilars in the various countries and why you don't always need to be the first on the market. You'll also get to know the opportunities still available for branded generics outside the EU now and in the near future.
    After having completed this seminar you will have a set of concrete ideas on how you could further improve your business development globally.

    Topics:
    - Risks and rewards of being late with biosimilars
    - China - a market for European generic plus products
    - How European companies can better penetrate LATAM
    - Using branded generics for expansion into emerging markets
    - The biosimilar global regulatory environment

    50.10814 8.66164
Wann 06.12.2013
von 09:00 bis 17:00
Veranstaltungsort Steigenberger Metropolitan
Stadt Frankfurt
Kontaktname
Kontakttelefon 06221 500 680
Zielgruppe This seminar addresses the needs of those
working in the generics and biosimilar
industry. Especialls managing directors and
managers from the following divisions will benefit from this course:
- R & D and regulatory affairs
- business development
- market access & sales
Termin übernehmen vCal
iCal

You will learn about the global regulatory framework for biosimilars in the various countries and why you don't always need to be the first on the market. You'll also get to know the opportunities still available for branded generics outside the EU now and in the near future.
After having completed this seminar you will have a set of concrete ideas on how you could further improve your business development globally.

Topics:
- Risks and rewards of being late with biosimilars
- China - a market for European generic plus products
- How European companies can better penetrate LATAM
- Using branded generics for expansion into emerging markets
- The biosimilar global regulatory environment

Direktbuchung

Weitere Informationen über diesen Termin…

FORUM Institut für Management GmbH

Programm

FORUM_Logo_JPEG.jpg — JPEG image, 599 kB (613,761 bytes)
Artikelaktionen